Solana (HSDT) Research Hub

Solana (HSDT) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 2.21 USD (-2.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.05, market cap 0.10B. This hub links to the full technical, earnings and options research available for HSDT.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNASDAQ, US
Last close2.21 USD (-2.21%)
52-week range1.45 USD – 3.42 USD
Trend regimeRange
14-day RSI26.8 (Oversold)
Trailing P/E-0.05
Market cap0.10B
Dividend yield0.00%
Next earnings2026-08-13

Available research for HSDT

Earnings

HSDT earnings date and last-quarter result: next report 2026-08-13, last quarter miss, P/E -0.05. Updated 2026-07-23.

Options: Covered Call

Covered Call on HSDT: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on HSDT: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on HSDT: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

HSDT technical analysis: range, last 2.21 USD, RSI 26.8, 52w range 1.45 USD–3.42 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is HSDT in?

Solana (HSDT) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.

Is HSDT in an uptrend or downtrend?

As of 2026-10-26, HSDT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is HSDT's trailing P/E ratio?

HSDT's trailing P/E is -0.05, with a market cap of 0.10B. See the earnings research page for full valuation detail.

When does HSDT next report earnings?

HSDT is next scheduled to report earnings on 2026-08-13.